Persistence of antibody to human parvovirus B19 after allogeneic bone marrow transplantation: role of prior recipient immunity

HA Ang, JF Apperley, KN Ward - Blood, The Journal of the …, 1997 - ashpublications.org
… On the other hand, as shown in the present work, B19 IgG antibody persistence after BMT
clearly depended on prior recipient immunity (Table 2 and Fig 2). These results cannot be …

Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study

R Sammut, L Feghoul, A Xhaard… - Transplant Infectious …, 2023 - Wiley Online Library
transplantation (alloHSCT) recipients and cause a persistentantibodies were negative.
Diagnosis of myositis linked to B19V … B19V PCR in bone marrow seems more sensitive than in …

Parvovirus B19 incidence, specific antibody response, and delayed hematopoietic recovery after allogeneic hematopoietic stem cell transplantation

AM Yu - Cellular Therapy and Transplantation, 2018 - cyberleninka.ru
… high prevalence of adaptive immune response. Generally, … in blood serum or bone marrow
from the HSCT recipients [9]. In … parvovirus B19 DNA in blood compartments and persistence

Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation

Y Koda, T Mori, J Kato, S Kohashi… - Transplant Infectious …, 2013 - Wiley Online Library
… solid organ transplant recipients. However, the pathogenesis of … Allogeneic bone marrow
transplantation from an ABO-… -PVB IgM antibody was produced by donor-derived immune cells …

Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology

M Söderlund, P Ruutu, T Ruutu… - … journal of infectious …, 1997 - Taylor & Francis
Parvovirus B19 infections can cause persistent anaemias or … by lytic B19 infection in the
absence of circulating antibodies. … of human parvovirus B19 infections in BMT recipients to date, …

Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic …

M Karrasch, V Schmidt, A Hammer, A Hochhaus… - …, 2017 - Taylor & Francis
Full article: Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent
pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem …

Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients

A Muetherig, M Christopeit, LP Müller… - … marrow transplantation, 2007 - nature.com
… study of parvovirus B19 antibody titres 2 to 3 years after bone marrow … , but not donor,
immunity. … It is known that human parvovirus B19 can persist in red blood cell precursors …

Severe multiorgan failure after parvovirus B19 infection in an allogeneic stem cell transplant recipient

HJ Klümpen, EJ Petersen, LF Verdonck - Bone marrow transplantation, 2004 - nature.com
… had a very delayed immune response to the parvovirus infection as the T-cell-… Immune
globulin to parvovirus B19 can control the persistent infection when an adequate patient antibody

[HTML][HTML] Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation

M Sundin, A Lindblom, C Örvell, AJ Barrett… - … Marrow Transplantation, 2008 - Elsevier
… -limiting with mild symptoms and results in lifelong immunity [17]… containing B19 in
immunocompromised recipients, however. … of B19 could be inhibited by adding anti-B19

Parvovirus B19 infection after transplantation: a review of 98 cases

AJ Eid, RA Brown, R Patel… - Clinical infectious …, 2006 - academic.oup.com
bone marrow transplants). A review of the medical records of … , which leads to persistent
PVB19 infection that manifests as … allow the immune system to mount specific immunity against …